Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Antibiotic therapy: A potential game-changer for hemodialysis treatment

An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System study.

3 Jul 2014

Use of catheter ablation lowers risk for atrial fibrillation

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.

1 Jul 2014

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Cordis Corporation announced today the launch of its SABER PTA Dilatation Catheter ("SABER Catheter") for the treatment of patients with Peripheral Arterial Disease (PAD).

1 Jul 2014

Researcher develops protector belt for patients receiving peritoneal dialysis

A lack of comfortable products for the safety of the patient requiring peritoneal dialysis-indicated to clean waste products from the blood when the kidneys fail- drove a student of the Higher Technological Institute of Choapas, Veracruz in the east coast of México, to develop an ergonomic support, allowing that the catheter inserted through the abdominal wall to remain in place and be protected from the invasion of microorganisms.

25 Jun 2014

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.

25 Jun 2014

Researchers employ mixture of saline and air bubbles to assess fallopian tubes

Many women struggling to become pregnant may suffer from some degree of tubal blockage. Traditionally, an x-ray hysterosalpingogram (HSG) that uses dye is the most common procedure to determine whether a blockage exists, but it can cause extreme discomfort to the patient.

24 Jun 2014

Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

A Huntington Memorial Hospital patient has become the first patient in the San Gabriel Valley to be implanted with a tiny, leadless cardiac pacemaker. Developed for patients with bradycardia - a heart rate that is too slow - the Nanostim device is designed to be placed directly in a patient's heart without the visible lump, scar and insulated wires (called leads) required for conventional pacemakers.

23 Jun 2014

NDC announces voluntary recall of HydroFinity Hydrophilic Guidewires

Nitinol Devices & Components, Inc. announced today a voluntary recall of its HydroFinity Hydrophilic Guidewires. The HydroFinity Guidewire is a product developed and manufactured by NDC and distributed by Covidien.

18 Jun 2014

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone.

18 Jun 2014

Doctors weigh how to use new heart-valve procedure

The procedure is less invasive than surgery but is still unproven for many patients, The Wall Street Journal reports. Meanwhile, the Journal also looks at how some doctors are using Google Glass to have more time with their patients.

17 Jun 2014

First Edition: June 17, 2014

Today's headlines include developments related to the health care marketplace and state health policy.

17 Jun 2014

Covidien receives FDA approval for Apollo Onyx delivery micro catheter

Covidien plc today announced U.S. Food and Drug Administration approval of its Apollo Onyx delivery micro catheter - the first detachable tip micro catheter available in the U.S.

11 Jun 2014

Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

Doctors at The Ohio State University Wexner Medical Center are the first in the country to begin treating some heart failure patients with a new wireless, implantable hemodynamic monitor that was just approved by the U.S. Food and Drug Administration. The monitor will help physicians observe pulmonary artery pressures, optimize treatment and prevent hospitalizations.

10 Jun 2014

Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding successful ways to stop germs from entering central line catheters and causing bloodstream infections in patients.

6 Jun 2014

Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

If you are shot or stabbed in or around Oakland, you are likely to be sent [to Highland Hospital). Oakland has the highest violent crime rate in the nation, so I have indeed seen my fair share of victims over my long career here.

6 Jun 2014

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.

5 Jun 2014

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period.

5 Jun 2014

Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.

5 Jun 2014

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions.

5 Jun 2014

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Millions of Americans depend on home health care services to recover from surgeries and hospital stays, as well as to manage daily life with chronic conditions.

4 Jun 2014

Catheter News and Research

Further Reading

Antibiotic therapy: A potential game-changer for hemodialysis treatment

Use of catheter ablation lowers risk for atrial fibrillation

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Researcher develops protector belt for patients receiving peritoneal dialysis

Cardium reports positive results from Generx Ad5FGF-4 Phase 3 study for treatment of myocardial ischemia

Researchers employ mixture of saline and air bubbles to assess fallopian tubes

Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

NDC announces voluntary recall of HydroFinity Hydrophilic Guidewires

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Doctors weigh how to use new heart-valve procedure

First Edition: June 17, 2014

Covidien receives FDA approval for Apollo Onyx delivery micro catheter

Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Disinfection caps reduce CLABSI events by 68%

Loyola achieves 68% decrease in central line-associated bloodstream infections

STENTYS signs agreement to acquire assets of Cappella Peel Away

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News